<DOC>
	<DOC>NCT01438736</DOC>
	<brief_summary>The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use.</brief_summary>
	<brief_title>Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Healthy women, 1840 years of age regular menstrual cycle (period 2335 days) Immediate previous use of progestin only contraception within 2 months Known or suspected pregnancy Acute tromboembolic disorder Presence or history of hepatic disease, as long as the liver function values have not returned to normal Undiagnosed vaginal bleeding Known or suspected sexsteroid influenced malignancies (e.g. breast cancer) Hypersensitivity to the active substances or to any of the excipients of the medicines Pregnant or breast feeding within 6 weeks The use of other medicinal products that might interact with contraceptive steroids and affect the efficacy of contraceptives and/or might may lead to bleeding irregularities (especially medicines that induce the liver enzyme systems such as cytochrome P450). Examples of active substances are: phenytoin, phenobarbital, primidone, bosentan, carbamatzepine, rifampicin and medicinal products or herbal preparations containing ST.John's wort and to a lesser extend oxcarbazepine, topiramate, felbamate and griseofulvin.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Focus:</keyword>
	<keyword>preceding</keyword>
	<keyword>desogestrel predicts</keyword>
	<keyword>pattern of following</keyword>
	<keyword>etonogestrel implant</keyword>
</DOC>